Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldebain vs Morphine for Postoperative Pain in Laparoscopic Cholecystectomy
NCT03713216Phase 4Completed
- Sponsor
- Cathay General Hospital
- Start
- Jul 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dinalbuphine sebacate in postoperative pain (2 arms), sponsored by Cathay General Hospital. Primary endpoint: Postoperative pain score at 24 hours. Started Jul 2018; status: completed.
02
Drugs
dinalbuphine sebacate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03713216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03713216.